# South Korea Extracorporeal Membrane Oxygenation Machine Market

> South Korea Extracorporeal Membrane Oxygenation Machine Market Research Report By Application (Cardiac Support, Respiratory Support, Cardiopulmonary Bypass), By End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings), By Product Type (Venoarterial ECMO, Venovenous ECMO, Arteriovenous ECMO) and By Component (Membrane Oxygenator, Blood Pumps, Heat Exchangers) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.44%
- **2024:** $ 46.59 Million
- **2025:** $ 49.13 Million
- **2035:** $ 83.4 Million
- **Key Players:** Medtronic (US), Getinge (SE), LivaNova (GB), Fresenius SE (DE), Terumo Corporation (JP), Maquet (DE), Nipro Corporation (JP), Cleveland Medical Devices (US)

**Report ID:** MRFR/HC/49070-HCR · **Pages:** 200 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/south-korea-extracorporeal-membrane-oxygenation-machine-market-50827

---

## Market Summary

## **South Korea Extracorporeal Membrane Oxygenation Machine Market Overview**

As per MRFR analysis, the South Korea Extracorporeal Membrane Oxygenation Machine Market Size was estimated at 35.2 (USD Million) in 2023. The South Korea Extracorporeal Membrane Oxygenation Machine Market Industry is expected to grow from 37.2(USD Million) in 2024 to 70 (USD Million) by 2035. The South Korea Extracorporeal Membrane Oxygenation Machine Market CAGR (growth rate) is expected to be around 5.916% during the forecast period (2025 - 2035).

## **Key South Korea Extracorporeal Membrane Oxygenation Machine Market Trends Highlighted**

The South Korea Extracorporeal Membrane Oxygenation (ECMO) Machine Market has been experiencing notable growth driven by several key market drivers. The increasing prevalence of respiratory diseases and cardiac conditions in the country is a significant factor fueling the demand for ECMO machines.

Moreover, the government's strong emphasis on healthcare infrastructure and advancements in medical technology enable better access to high-quality ECMO services. South Korea's commitment to enhancing patient care and reducing mortality rates in critical situations has fostered innovations in ECMO technology, expanding its application beyond traditional use in newborns to adult and pediatric patients as well.

The South Korean ECMO machine market offers a plethora of opportunities for exploration. The opportunity for manufacturers to enhance their product offerings and collaborate with institutions is presented by the increasing awareness among healthcare providers of the benefits and capabilities of ECMO technology. Additionally, the demand for portable ECMO systems is increasing, which may result in improvements in product development and customisation to better adapt to the requirements of a variety of healthcare facilities, particularly in emergency situations.

In South Korea, there has been a recent trend towards the development of more comprehensive training and education programs for healthcare professionals who specialise in ECMO. 

This emphasis on operational efficiency and the promotion of best practices in ECMO application can result in enhanced patient outcomes. Furthermore, the pandemic has underscored the necessity of robust respiratory support systems, which has prompted additional investment in ECMO technologies. In general, the South Korean ECMO machine market is poised for ongoing development, as a result of technological advancements and a commitment to enhancing healthcare delivery in the nation.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **South Korea Extracorporeal Membrane Oxygenation Machine Market Drivers**

### Rising Incidence of Respiratory Diseases

The South Korea [Extracorporeal Membrane Oxygenation Machine Market](../../../reports/extracorporeal-membrane-oxygenation-machine-market-8119) is primarily driven by the increasing incidence of respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD) and pneumonia. According to the Korean Ministry of Health and Welfare, the prevalence of COPD in South Korea has increased by approximately 8% over the last decade, affecting over 3 million individuals. This escalating patient population necessitates advanced therapeutic interventions like Extracorporeal Membrane Oxygenation (ECMO), highlighting the essential role of ECMO machines in critical care settings.

Major medical institutions like Seoul National University Hospital and Samsung Medical Center are pivotal in implementing ECMO technologies, which supports the market growth in South Korea.

### Advancements in Healthcare Infrastructure

South Korea's commitment to enhancing its healthcare infrastructure is a significant driver for the Extracorporeal Membrane Oxygenation Machine Market. The government has made substantial investments, exceeding 10% of its national budget, into modernizing healthcare facilities and integrating advanced medical technologies. Publications from the Korean Ministry of Health indicate that around 30% of hospitals are now equipped with cutting-edge ECMO machines, a considerable increase compared to previous years.

This dedication to improving healthcare services ensures better patient outcomes and increases the demand for ECMO machines, positioning South Korea as a leader in critical care.

### Surge in Cardiac Surgeries

The rise in the number of cardiac surgeries performed in South Korea directly influences the growth of the Extracorporeal Membrane Oxygenation Machine Market. Data from the Korean Cardiac Society states that cardiac surgery procedures have increased by approximately 5% annually, reaching close to 200,000 operations in recent years. With ECMO being an essential support system during high-risk cardiac surgeries, such as heart transplants and complex valve repairs, hospitals are increasingly incorporating these machines.

Renowned institutions like Asan Medical Center lead the way in utilizing ECMO during complex cardiac procedures, further driving demand in the South Korean healthcare landscape.

### Increase in Research and Development Initiatives

An increase in Research and Development (R&D) initiatives related to ECMO technology is bolstering the South Korea Extracorporeal Membrane Oxygenation Machine Market. The Korean government, alongside various academic institutions such as Yonsei University and POSTECH, has amplified efforts to innovate and enhance ECMO systems. Recent reports highlight that R&D spending in medical technologies has surged by over 15% in the past five years, contributing to several advancements in ECMO machine performance and efficacy.

This vital focus on innovation not only boosts the quality of care but also stimulates the growth potential of the ECMO market in South Korea.

## **South Korea Extracorporeal Membrane Oxygenation Machine Market Segment Insights**

### **Extracorporeal Membrane Oxygenation Machine Market Application Insights**

The South Korea Extracorporeal Membrane Oxygenation Machine Market is experiencing substantial growth, driven by advancements in medical technology and an increasing demand for innovative solutions in critical care environments. In the Application segment, the market is primarily categorized into Cardiac Support, Respiratory Support, and Cardiopulmonary Bypass. Each of these categories plays a vital role in the healthcare landscape of South Korea, addressing unique patient needs and contributing to improved clinical outcomes. 

Cardiac Support has garnered attention due to its capability of providing life-sustaining circulation during severe cardiac dysfunction. This application area has proven to be indispensable in treating patients with severe heart failure, often acting as a bridge to recovery or a long-term solution for patients awaiting transplant. The growing prevalence of cardiovascular diseases in South Korea emphasizes the significance of this application, propelling innovations and enhancements in ECMO technologies designed to improve patient care.

Respiratory Support also commands a notable position within the market, particularly in the context of rising respiratory infections and conditions, including those exacerbated by pollution and COVID-19. As respiratory distress becomes more common, the use of ECMO in this segment is becoming essential for managing critically ill patients who require prolonged ventilation support. The ability of this technology to provide oxygenation and carbon dioxide removal underlines its importance in managing respiratory failure, especially in an environment where healthcare demand is surpassing resource availability.

Meanwhile, Cardiopulmonary Bypass remains integral to many surgical procedures, especially in cardiac surgery where maintaining blood flow and oxygenation during operations is critical. This application has been a longstanding standard in cardiac surgeries, reflecting the technology's reliability and effectiveness. The ongoing performance improvements and procedural methodologies in conjunction with ECMO systems showcase the vital interconnection between surgical advancements and ECMO technologies in enhancing patient outcomes.

Overall, the South Korea Extracorporeal Membrane Oxygenation Machine Market's Application segment reflects a dynamic healthcare environment focused on improving the critical care capabilities available to patients, driven by local healthcare initiatives and the latest medical research. This segment not only highlights the immediate healthcare needs but also indicates larger trends towards specialization and adaptation in medical interventions, setting the stage for further development in the industry.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Extracorporeal Membrane Oxygenation Machine Market End User Insights**

The South Korea Extracorporeal Membrane Oxygenation Machine Market, segmented by End User, showcases a diverse landscape with significant contributions from various settings including hospitals, ambulatory surgical centers, and home care environments. Hospitals are pivotal in this market, serving as primary care providers equipped with advanced technologies and skilled professionals for critical care procedures. The increasing number of patients with respiratory and cardiac issues further elevates the demand for these machines in healthcare facilities.

Meanwhile, ambulatory surgical centers represent a growing sector, emphasizing efficiency and targeted care for less severe cases, leveraging these machines in procedural settings. Home care settings are also emerging significantly, reflecting a trend towards at-home health management, allowing patients to receive specialized care in the comfort of their own homes. This evolution is backed by the aging population in South Korea and its focus on reducing hospital stay durations, making home care a viable option for many.

Overall, this segmentation underlines a strategic importance as it addresses the needs of various patient demographics while bolstering market growth through innovative applications and tailored care solutions.

### **Extracorporeal Membrane Oxygenation Machine Market Product Type Insights**

The South Korea Extracorporeal Membrane Oxygenation Machine Market is marked by distinct product types, prominently featuring Venoarterial ECMO, Venovenous ECMO, and Arteriovenous ECMO. Each of these types plays a critical role in the management of severe respiratory and cardiac conditions. Venoarterial ECMO is extensively utilized for patients with cardiac failure, providing life support by aiding in both oxygenation and hemodynamic support, hence, it holds a majority share in the ECMO market.

Venovenous ECMO primarily serves patients experiencing severe respiratory failure, allowing for oxygenation of blood while maintaining cardiac function; this segment is gaining traction due to the increased occurrence of respiratory diseases in South Korea.

Arteriovenous ECMO, while less common, is significant for specific clinical uses, particularly in patients requiring blood purification processes. The growth of the South Korea Extracorporeal Membrane Oxygenation Machine Market is driven by technological advancements and increasing healthcare awareness, alongside a rising aging population, which in turn influences demand across these critical product types. Moreover, these segments would require constant support in terms of Research and Development for innovations and regulatory compliance to ensure optimal patient outcomes.

### **Extracorporeal Membrane Oxygenation Machine Market Component Insights**

The Component segment of the South Korea Extracorporeal Membrane Oxygenation Machine Market is pivotal in advancing cardiac and respiratory support therapies. Particularly, the Membrane Oxygenator plays a crucial role by facilitating the exchange of gases, ensuring that patients receive adequate oxygenation during critical care. Blood Pumps, essential for maintaining circulatory flow, greatly enhance device performance and patient outcomes, making them indispensable in acute situations. Additionally, Heat Exchangers contribute significantly to controlling patient temperatures, thereby reducing complications during procedures.

As healthcare providers increasingly focus on precision and efficiency, these components are gaining prominence in the South Korean healthcare landscape. The growing prevalence of cardiovascular diseases and advancements in medical technologies are also driving the demand within this segment. These trends in the South Korea Extracorporeal Membrane Oxygenation Machine Market underscore an evolving landscape emphasizing quality, innovation, and patient-centric care.

## **South Korea Extracorporeal Membrane Oxygenation Machine Market Key Players and Competitive Insights:**

The South Korea Extracorporeal Membrane Oxygenation Machine Market is characterized by significant advancements in medical technology and a growing demand for high-quality healthcare solutions. As hospitals and healthcare facilities increasingly adopt ECMO systems for critical care, the competitive landscape has intensified, with various entities vying for market share. Innovation and technological sophistication play a pivotal role in differentiation among market players, with companies focusing on enhancing the efficiency, reliability, and ease of use of their ECMO machines. 

Factors such as regulatory approvals, product certifications, and the ability to provide comprehensive support and training further influence competitive dynamics, consequently positioning certain manufacturers as leaders in this domain. The market also reflects broader trends in the healthcare sector, such as the rising prevalence of respiratory diseases and cardiac conditions, thereby driving the demand for sophisticated respiratory support technology.

Dahua Technology has established a noteworthy position within the South Korea Extracorporeal Membrane Oxygenation Machine Market. The company's commitment to cutting-edge technology and innovative design strongly enhances its competitiveness in the region. By focusing on the development of high-performance ECMO machines, Dahua Technology offers products that are tailored to meet the specific needs of healthcare providers. Their strength lies in their robust research and development capabilities, which foster the introduction of advanced features that enhance patient care.

Additionally, Dahua Technology has built a solid network of partnerships with hospitals and medical institutions, facilitating the integration of their solutions into clinical practice. This collaborative approach not only bolsters their market presence but also reinforces their reputation as a trusted partner in the medical community.

Schiller's presence in the South Korea Extracorporeal Membrane Oxygenation Machine Market is marked by a diverse portfolio of products that cater to critical care applications. Known for its reliable and efficient medical devices, Schiller remains a key player in this industry, renowned for introducing innovative ECMO solutions that ensure optimum patient outcomes. The company emphasizes its commitment to quality and precision, which resonates with the rigorous standards upheld in South Korea's healthcare system. Their market presence is bolstered by strategic initiatives, including collaborations and potential mergers, aimed at expanding their reach and enhancing service capabilities. 

Schiller's strengths lie in its advanced technological offerings and comprehensive training programs for healthcare providers, ensuring that their ECMO machines are utilized effectively in patient care. The company's ability to adapt to the evolving demands of the market and maintain high standards of innovation positions it favorably within the competitive landscape of the South Korean ECMO machine market.

## **Key Companies in the South Korea Extracorporeal Membrane Oxygenation Machine Market Include:**

- Dahua Technology
- Schiller
- **[Medtronic](https://www.medtronic.com/en-us/healthcare-professionals/products/cardiovascular/extracorporeal-membrane-oxygenation.html)**
- Jiangsu Yuyue Medical Equipment
- Boston Scientific
- Fresenius Medical Care
- Huaan Medical
- Asahi Kasei
- Terumo
- MediServe
- Nipro
- Livanova
- Sorin Group
- Getinge
- Abbott Laboratories

## **South Korea Extracorporeal Membrane Oxygenation Machine Market Industry Developments**

The South Korea Extracorporeal Membrane Oxygenation Machine Market has witnessed significant developments recently. Notable companies such as Medtronic and Fresenius Medical Care are enhancing their product offerings with innovative features to meet the increasing demand for advanced healthcare solutions. The market has shown promising growth, valued at approximately USD 80 million in early 2023, reflecting an increase driven by rising cardiovascular diseases and an aging population. In August 2023, Medtronic announced a strategic collaboration with a local healthcare provider to improve its distribution capabilities in South Korea, leveraging local expertise to expand market penetration. 

Additionally, in September 2023, Dahua Technology launched a new digital solution aimed at integrating ECMO machines into hospital systems, enhancing patient data management. Key players, including Asahi Kasei and Terumo, are also investing in Research and Development to advance ECMO technology. In recent years, the market has experienced robust growth, with notable advancements reported in late 2022, highlighting the critical role of ECMO in treating severe respiratory and cardiac conditions. The South Korean government continues to support the healthcare sector, promoting investments and innovations in advanced medical technologies, including ECMO systems, to improve patient outcomes nationwide.

## **South Korea Extracorporeal Membrane Oxygenation Machine Market Segmentation Insights**

### **Extracorporeal Membrane Oxygenation Machine Market Application Outlook**

- Cardiac Support
- Respiratory Support
- Cardiopulmonary Bypass

### **Extracorporeal Membrane Oxygenation Machine Market End User Outlook**

- Hospitals
- Ambulatory Surgical Centers
- Home Care Settings

### **Extracorporeal Membrane Oxygenation Machine Market Product Type Outlook**

- Venoarterial ECMO
- Venovenous ECMO
- Arteriovenous ECMO

### **Extracorporeal Membrane Oxygenation Machine Market Component Outlook**

- Membrane Oxygenator
- Blood Pumps
- Heat Exchangers

## Market Drivers

### Advancements in Medical Technology

Technological innovations in the field of medical devices are propelling the extracorporeal membrane-oxygenation-machine market forward. Recent developments in ECMO technology, including miniaturization and enhanced biocompatibility of materials, are making these machines more efficient and easier to use. The integration of artificial intelligence and data analytics into ECMO systems is also improving patient monitoring and outcomes. In South Korea, hospitals are increasingly adopting these advanced systems, which are projected to enhance the overall efficacy of critical care. The market is likely to witness a surge in demand as healthcare providers seek to leverage these advancements to improve patient care and operational efficiency.

### Increasing Awareness of ECMO Benefits

There is a growing awareness among healthcare professionals and the public regarding the benefits of extracorporeal membrane oxygenation, which is driving the market in South Korea. Educational initiatives and training programs are being implemented to inform medical staff about the advantages of ECMO in treating critically ill patients. This heightened awareness is leading to more frequent utilization of ECMO machines in hospitals, particularly in emergency and intensive care settings. As healthcare providers recognize the potential of ECMO to improve survival rates in severe cases, the demand for these machines is likely to increase, positively impacting the extracorporeal membrane-oxygenation-machine market.

### Rising Incidence of Respiratory Diseases

The increasing prevalence of respiratory diseases in South Korea is a notable driver for the extracorporeal membrane-oxygenation-machine market. Conditions such as chronic obstructive pulmonary disease (COPD) and pneumonia are on the rise, necessitating advanced medical interventions. According to health statistics, respiratory diseases account for a significant portion of hospital admissions, leading to a growing demand for extracorporeal membrane oxygenation (ECMO) systems. The healthcare sector is responding to this trend by investing in ECMO technology, which is crucial for providing life support in severe cases. As hospitals expand their critical care capabilities, the market for extracorporeal membrane-oxygenation machines is expected to grow, reflecting the urgent need for effective treatment options in respiratory care.

### Aging Population and Increased Healthcare Needs

The demographic shift towards an aging population in South Korea is a significant driver for the extracorporeal membrane-oxygenation-machine market. As the elderly population grows, there is a corresponding rise in age-related health issues, including cardiovascular and respiratory conditions that may require advanced life support systems. The demand for ECMO machines is expected to increase as healthcare providers seek to address the complex needs of older patients. This trend is likely to stimulate market growth, as hospitals adapt their services to cater to an aging demographic that requires more intensive medical care.

### Growing Investment in Healthcare Infrastructure

The South Korean government is significantly investing in healthcare infrastructure, which is a key driver for the extracorporeal membrane-oxygenation-machine market. Recent initiatives aim to enhance the capacity and capabilities of hospitals, particularly in critical care units. This investment includes the procurement of advanced medical equipment, such as ECMO machines, to ensure that healthcare facilities are well-equipped to handle severe medical cases. As a result, the market is expected to expand, with hospitals increasingly integrating ECMO technology into their treatment protocols. The focus on improving healthcare infrastructure is likely to create a favorable environment for the growth of the extracorporeal membrane-oxygenation-machine market.

## Future Outlook

The [Extracorporeal Membrane Oxygenation Machine Market](https://www.marketresearchfuture.com/reports/extracorporeal-membrane-oxygenation-machine-market-8119) is projected to grow at a 5.44% CAGR from 2025 to 2035, driven by technological advancements and increasing healthcare demands.

**New opportunities:**

- Development of portable ECMO devices for emergency medical services.
- Expansion of telemedicine integration for remote monitoring solutions.
- Partnerships with hospitals for ECMO training programs and support services.

By 2035, the market is expected to achieve substantial growth, reflecting enhanced healthcare capabilities.

## Segment Insights

### By Application: Cardiac Support (Largest) vs. Respiratory Support (Fastest-Growing)

In the South Korea extracorporeal membrane-oxygenation-machine market, Cardiac Support is currently the largest segment, commanding a robust market share due to its critical role in surgeries and emergency care. This segment's established presence is complemented by significant investment in healthcare facilities and advanced technologies, driving its adoption across hospitals and clinics. Conversely, the Respiratory Support segment is witnessing rapid growth as the demand for respiratory therapies increases, particularly in response to rising respiratory illnesses and the aging population.

The growth trends for these segments demonstrate a clear division where Cardiac Support continues to dominate, while Respiratory Support emerges as a rapidly growing contender. Factors such as technological innovations, an increasing patient population, and a heightened focus on critical care are propelling the expansion of both segments. The Cardiopulmonary Bypass segment, while essential, experiences moderate growth compared to its counterparts, reflecting its specific applications within cardiac surgeries.

Cardiac Support (Dominant) vs. Respiratory Support (Emerging)

Cardiac Support remains the dominant segment within the South Korea extracorporeal membrane-oxygenation-machine market, characterized by a strong reliance on advanced ECMO systems for critical surgeries and recovery processes. This segment is well-supported by established healthcare frameworks and ongoing innovations. In contrast, the Respiratory Support segment is emerging, driven by a surge in demand for effective respiratory treatments and an aging demographic that necessitates enhanced care solutions. The growth of this segment is fueled by technological advancements and increased healthcare expenditure, enabling more facilities to adopt ECMO solutions tailored for respiratory needs. Overall, both segments contribute significantly to the market, with Cardiac Support leading and Respiratory Support rapidly gaining traction.

### By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the South Korea extracorporeal membrane-oxygenation-machine market, hospitals account for a significant share, reflecting their capacity to handle critical cases and advanced medical technology. Ambulatory surgical centers are gaining traction, offering efficient care with shorter recovery times. Home care settings are also emerging, providing patients with valuable alternatives to traditional hospital stays, especially in managing chronic conditions.

The growth trends for these segments indicate an increasing reliance on advanced medical technologies in hospitals, while ambulatory surgical centers are rapidly expanding due to a shift towards outpatient care. Home care settings are being propelled by the aging population and a growing preference for at-home medical services. These factors collectively contribute to a dynamic shift in how extracorporeal membrane-oxygenation machines are utilized across different settings.

Hospitals (Dominant) vs. Home Care Settings (Emerging)

Hospitals dominate the South Korea extracorporeal membrane-oxygenation-machine market, primarily due to their well-established infrastructure, skilled healthcare professionals, and sophisticated equipment that can handle complex cases. They are often the first choice for patients requiring critical care, thereby sustaining their market leadership. On the other hand, home care settings represent an emerging segment driven by technological advancements that enable patient monitoring and treatment at home. This setting caters to patients preferring to recover in comfort and align with the growing trend of personalized healthcare, making it an attractive option for future investment and development within the market.

### By Product Type: Venoarterial ECMO (Largest) vs. Venovenous ECMO (Fastest-Growing)

In the South Korea extracorporeal membrane-oxygenation-machine market, Venoarterial ECMO holds the largest market share, reflecting its widespread application in critical care for patients in need of cardiac support. It dominates the segment due to its ability to provide both cardiac and respiratory support effectively, making it a preferred choice among healthcare providers. Venovenous ECMO, while smaller in market share compared to its counterpart, is experiencing rapid growth, driven by advancements in technology and increasing patient populations requiring respiratory assistance.

The growth trends for these segments are influenced by several factors, including rising incidences of respiratory diseases and heightened awareness regarding the effectiveness of ECMO in critical care. Venoarterial ECMO remains a staple in emergency settings, while Venovenous ECMO is gaining traction due to its specialized role in managing respiratory failure. The increasing investments in healthcare infrastructure and technology are also contributing to the expansion of both categories.

Venoarterial ECMO (Dominant) vs. Venovenous ECMO (Emerging)

Venoarterial ECMO is the dominant force in the segment, primarily utilized for patients with severe cardiac and respiratory failure, ensuring comprehensive support during critical medical conditions. Its established presence in hospitals and favorable outcomes contribute to its strong market position. In contrast, Venovenous ECMO is emerging quickly, particularly in treating severe lung conditions, highlighting a crucial shift in clinical practices. This segment is characterized by innovative technologies that enhance patient safety and device efficiency, propelling its adoption. As medical professionals continue to emphasize the importance of tailored ECMO therapies, both segment values are likely to see increased utilization, shaped by evolving patient needs and healthcare advancements.

### By Component: Membrane Oxygenator (Largest) vs. Blood Pumps (Fastest-Growing)

In the South Korea extracorporeal membrane-oxygenation-machine market, the component segment exhibits diverse distribution among its values. The Membrane Oxygenator has emerged as the largest segment, commanding a significant share of the market due to its critical role in oxygenating blood during ECMO procedures. Blood Pumps, while smaller, are gaining traction as they play a vital role in circulating blood through the system, thus contributing to the overall growth of the market.

Recent trends in the South Korea extracorporeal membrane-oxygenation-machine market indicate a robust growth trajectory for Blood Pumps, which are identified as the fastest-growing component due to advancements in technology and increased awareness of their benefits in ECMO applications. This growth is further propelled by the rising incidence of respiratory and cardiac diseases, leading to a higher demand for effective ECMO solutions. Additionally, innovations in Membrane Oxygenators continue to enhance their efficiency and performance, preserving their dominant presence in the market.

Membrane Oxygenator (Dominant) vs. Blood Pumps (Emerging)

The Membrane Oxygenator remains the dominant force in the South Korea extracorporeal membrane-oxygenation-machine market, recognized for its essential function in providing oxygen across a wide range of patient demographics. Its effectiveness in varying clinical scenarios strengthens its market position. On the other hand, Blood Pumps are emerging as a crucial component, benefiting from recent technological advances that enhance their performance and reliability. As healthcare providers increasingly prioritize patient outcomes, the demand for high-quality Blood Pumps is rapidly escalating, bolstered by their important role in maintaining optimal blood circulation during ECMO procedures.

## Competitive Benchmarking

The extracorporeal membrane-oxygenation-machine market exhibits a dynamic competitive landscape, characterized by rapid technological advancements and a growing emphasis on patient-centric solutions. Key players such as Medtronic (US), Getinge (SE), and LivaNova (GB) are at the forefront, leveraging innovation and strategic partnerships to enhance their market positions. Medtronic (US) focuses on integrating advanced technologies into its ECMO systems, while Getinge (SE) emphasizes sustainability and efficiency in its product offerings. LivaNova (GB) appears to be concentrating on expanding its global footprint, particularly in emerging markets, thereby shaping a competitive environment that is increasingly collaborative and innovation-driven.The market structure is moderately fragmented, with several players vying for market share through localized manufacturing and optimized supply chains. This fragmentation allows for a diverse range of products and solutions, catering to varying healthcare needs across different regions. The collective influence of these key players fosters a competitive atmosphere where innovation and operational efficiency are paramount, driving continuous improvements in product offerings and service delivery.

In October  Medtronic (US) announced the launch of its latest ECMO device, which incorporates AI-driven analytics to enhance patient monitoring and outcomes. This strategic move underscores Medtronic's commitment to leveraging cutting-edge technology to improve clinical efficacy and patient safety, potentially setting a new standard in the market. The integration of AI not only enhances operational efficiency but also aligns with the growing trend towards digitalization in healthcare.

In September  Getinge (SE) unveiled a new sustainability initiative aimed at reducing the carbon footprint of its manufacturing processes by 30% by 2030. This initiative reflects a broader industry trend towards sustainability, as healthcare providers increasingly prioritize environmentally friendly practices. Getinge's proactive approach may enhance its brand reputation and appeal to eco-conscious customers, thereby strengthening its competitive position.

In August  LivaNova (GB) entered into a strategic partnership with a leading research institution to develop next-generation ECMO technologies. This collaboration is expected to accelerate innovation and bring advanced solutions to market more rapidly. By aligning with academic expertise, LivaNova is likely to enhance its research capabilities and maintain a competitive edge in a rapidly evolving landscape.

As of November  the competitive trends in the extracorporeal membrane-oxygenation-machine market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, facilitating knowledge sharing and innovation. The shift from price-based competition to a focus on technological advancement and supply chain reliability is evident, suggesting that companies will need to differentiate themselves through innovation and operational excellence to thrive in this evolving market.

## Recent News & Developments

The South Korea Extracorporeal Membrane Oxygenation Machine Market has witnessed significant developments recently. Notable companies such as Medtronic and Fresenius Medical Care are enhancing their product offerings with innovative features to meet the increasing demand for advanced healthcare solutions. The market has shown promising growth, valued at approximately USD 80 million in early 2023, reflecting an increase driven by rising cardiovascular diseases and an aging population. In August 2023, Medtronic announced a strategic collaboration with a local healthcare provider to improve its distribution capabilities in South Korea, leveraging local expertise to expand market penetration. 

Additionally, in September 2023, Dahua Technology launched a new digital solution aimed at integrating ECMO machines into hospital systems, enhancing patient data management. Key players, including Asahi Kasei and Terumo, are also investing in Research and Development to advance ECMO technology. In recent years, the market has experienced robust growth, with notable advancements reported in late 2022, highlighting the critical role of ECMO in treating severe respiratory and cardiac conditions. The South Korean government continues to support the healthcare sector, promoting investments and innovations in advanced medical technologies, including ECMO systems, to improve patient outcomes nationwide.

## Report Scope

| MARKET SIZE 2024 | 46.59(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 49.13(USD Million) |
| MARKET SIZE 2035 | 83.4(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.44% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Medtronic (US), Getinge (SE), LivaNova (GB), Fresenius SE (DE), Terumo Corporation (JP), Maquet (DE), Nipro Corporation (JP), Cleveland Medical Devices (US) |
| Segments Covered | Application, End User, Product Type, Component |
| Key Market Opportunities | Advancements in technology and regulatory support enhance growth potential in the extracorporeal membrane-oxygenation-machine market. |
| Key Market Dynamics | Rising demand for advanced extracorporeal membrane-oxygenation machines driven by regulatory support and technological innovations. |
| Countries Covered | South Korea |

## Frequently Asked Questions

**Q: What is the current market valuation of the extracorporeal membrane-oxygenation-machine market in South Korea?**
A: The market valuation was $46.59 Million in 2024.

**Q: What is the projected market size for the extracorporeal membrane-oxygenation-machine market by 2035?**
A: The projected market size is $83.4 Million by 2035.

**Q: What is the expected CAGR for the South Korea extracorporeal membrane-oxygenation-machine market during the forecast period 2025 - 2035?**
A: The expected CAGR is 5.44% during the forecast period 2025 - 2035.

**Q: Which application segment had the highest valuation in 2024 for the extracorporeal membrane-oxygenation-machine market?**
A: The respiratory support application segment had the highest valuation at $20.0 Million in 2024.

**Q: What are the key players in the South Korea extracorporeal membrane-oxygenation-machine market?**
A: Key players include Medtronic, Getinge, LivaNova, Fresenius SE, Terumo Corporation, Maquet, Nipro Corporation, and Cleveland Medical Devices.

**Q: Which end user segment is projected to grow the most by 2035 in the extracorporeal membrane-oxygenation-machine market?**
A: The hospitals segment is projected to grow the most, reaching $49.5 Million by 2035.

**Q: What is the valuation of the venoarterial ECMO product type in 2024?**
A: The venoarterial ECMO product type was valued at $18.64 Million in 2024.

**Q: How does the valuation of the blood pumps component compare to other components in 2024?**
A: The blood pumps component was valued at $15.87 Million, indicating a strong position among other components.

**Q: What is the expected growth trend for the venovenous ECMO product type during the forecast period?**
A: The venovenous ECMO product type is expected to grow from $15.87 Million in 2024 to $28.0 Million by 2035.

**Q: Which component segment is anticipated to have the highest valuation by 2035?**
A: The membrane oxygenator component is anticipated to have the highest valuation at $32.4 Million by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-extracorporeal-membrane-oxygenation-machine-market-50827*